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IL-20 Gene Expression Is Induced by IL-1b through
Mitogen-Activated Protein Kinase and
NF-jB-Dependent Mechanisms
Kristian Otkjaer1, Knud Kragballe1, Claus Johansen1, Anne T. Funding1, Helle Just1, Uffe B. Jensen2,
Lotte G. Sørensen3, Peder L. Nørby3, Jes T. Clausen3 and Lars Iversen1
IL-20 is a novel member of the IL-10 cytokine family with pleiotropic effects. Current knowledge of what triggers
and regulates IL-20 gene expression is sparse. The aim of this study was to investigate the regulation of IL-20
expression in cultured normal human keratinocytes. The expression of IL-20 was rapidly induced by
proinflammatory stimuli, in particular IL-1b, IL-6, and UVB irradiation. Using kinase inhibitors and small-
interfering RNA, we discovered that the p38 mitogen-activated protein kinase (MAPK) as well as inhibitory kB
kinase -NF-kB signaling pathways are crucial for IL-20 expression. By electrophoretic mobility shift assay two kB-
binding sites were identified upstream from the start codon in the IL-20 gene. Supershift analysis revealed
binding of the p50/p65 heterodimer. Furthermore, the p38 MAPK was shown to exert its effects on IL-20
expression through activation of the downstream kinase mitogen- and stress-activated kinase 1 (MSK1),
indicating transactivation of NF-kB driven IL-20 messenger RNA transcription as an important mechanism of
action. IL-20 is assumed to be a key cytokine in the pathogenesis of psoriasis and possibly cancer, and therefore
the p38 MAPK, MSK1, and NF-kB may be important new molecular targets for the modulation of IL-20 expression
in these diseases.
Journal of Investigative Dermatology (2007) 127, 1326–1336. doi:10.1038/sj.jid.5700713; published online 25 January 2007
INTRODUCTION
IL-20 was discovered in a keratinocyte complementary DNA
library, mapped to the human chromosome 1q32 and based on
its coding sequence classified as a member of the IL-10 family
of cytokines (Blumberg et al., 2001). IL-20 signals through a
heterodimeric receptor complex, which consists of the receptor
subunit IL-20Rb together with either IL-20Ra or IL-22Ra.
Current knowledge of the biological effects of IL-20 is
sparse. In cultured BaF3 cell lines transfected with IL-20
receptor complexes, IL-20 induces cell proliferation (Parrish-
Novak et al., 2002). IL-20 also possesses angiogenic
capabilities (Hsieh et al., 2006) and selectively enhances
proliferation of multipotential hematopoietic progenitor cells
(Liu et al., 2003). Transgenic mice overexpressing IL-20
develop a tight, wrinkled skin and die a few days after birth
(Blumberg et al., 2001). Further analysis of the skin revealed a
compact stratum corneum, hyperproliferation, and altered
differentiation of the keratinocytes resembling some of the
characteristics of the chronic inflammatory skin disease
psoriasis (Blumberg et al., 2001). We have previously reported
IL-20 messenger RNA (mRNA) expression to be strongly
upregulated in lesional psoriatic skin compared with non-
lesional psoriatic skin. This increased IL-20 mRNA expression
decreased in parallel with the clinical and histological
improvement of the disease during treatment (Otkjaer et al.,
2005). Furthermore, in a xenograft model of psoriasis in
immunodeficient mice, IL-20 administration induces disease
activity in transplanted human non-lesional psoriatic skin.
Treatment of psoriasis in the same mouse model with a
polyclonal rabbit anti-IL-20 antibody improved psoriasis
comparable to that achieved by the Immunosuppressant drug
ciclosporin A (Kjeldsen C.R., Stenderup K., Dagnaes-Hansen
F., Steiniche T., Hasselager E., Iversen L., Zahn S., Holmberg
H.L., Worsaae A., Roemer J., Kragballe K., Clausen J.T., Dam
T.N. (2005). Abstr. 053, J Invest Dermatol 124, (Suppl),
(Abstr.)). Taken together these findings indicate a key role for
IL-20 in the pathogenesis of psoriasis.
IL-20 has so far been detected in skin, trachea, blood,
lung, and brain (Blumberg et al., 2001; Wolk et al., 2002;
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Hosoi et al., 2004; Heuze-Vourc’h et al., 2005). Cell types
demonstrated to express IL-20 mRNA are monocytes, murine
brain glial cells, and bronchial-epithelial cells (Blumberg
et al., 2001; Wolk et al., 2002; Hosoi et al., 2004; Heuze-
Vourc’h et al., 2005). Assessed by in situ hybridization, the
keratinocyte was suggested as the predominant cellular
source of IL-20 mRNA in lesional psoriatic skin (Romer
et al., 2003). However, this cell type has not yet been
explicitly demonstrated to express IL-20 protein.
Lipopolysaccharide can induce IL-20 mRNA expression in
monocytes and glial cells, but apart from this very little is
known about what triggers and regulates IL-20 gene
expression. In brain microglial cells the lipopolysaccharide-
induced IL-20 mRNA expression is mediated by MyD88- and
p38 mitogen-activated protein kinase (MAPK)-dependent
mechanisms (Hosoi et al., 2004).
The aim of this study was to investigate the in vitro
expression of IL-20. We identified the human keratinocyte as
an IL-20 producing cell and used it as a model to investigate
IL-20 expression. We also identified several, previously
unknown, inducers of IL-20 gene expression and, studied
for the first time, the kinetics of IL-20 gene expression
extensively. It was demonstrated that the MAPK and the
inhibitory kB-kinase (IKK)-NF-kB pathways are key regulators
of IL-20 expression, and discovered that a simultaneous
activation of these pathways was mediated by transforming
growth factor-b-activated kinase (TAK1) and MAPK kinase
kinase 3 (MEKK3).
RESULTS
Human keratinocytes grown in vitro express IL-20 mRNA
Lipopolysaccharide-stimulated monocytes have previously
been reported to express IL-20 mRNA (Wolk et al., 2002).
Therefore, the primary keratinocyte cultures used in this study
were analyzed for monocyte lineage cells contamination.
Flowcytometric analyses with antibodies against the imma-
ture Langerhans cell marker, cluster of differentiation
molecule 1a (CD1a) and the monocyte lineage cell marker
CD14 revealed less than 0.1% positive cells. With the use of
FACS, the diminutive proportion of CD1aþ and CD14þ
cells were removed from the cultures. RNA was purified from
the remaining cells (not stimulated) and basal IL-20 mRNA
expression levels relative to housekeeping gene 18 seconds
rRNA were determined with quantitative real-time RT-PCR.
Removal of CD1aþ and CD14þ cells did not affect IL-20
mRNA expression levels compared with unsorted unstimu-
lated cultures (data not shown). On average 95% of unsorted
NHEK were strongly positive for of keratin 14 (data not
shown).
IL-20 expression in human keratinocytes is induced by IL-1b, IL-
1a, UVB, and IL-6
To identify factors capable of inducing IL-20 gene expression,
NHEK were incubated with various proinflammatory and
pro-differentiating stimuli for 2 and 6 hours. Stimulation with
IL-1b, IL-1a, UVB, or IL-6 for 2 hours led to a significant
increase in IL-20 mRNA expression in NHEK, whereas
incubation with IFN-g, calcium and IL-20 did not affect IL-20
mRNA expression (Figure 1a). After 6 hours of stimulation IL-
20 mRNA levels had returned to normal, except in UVB and
IL-6-stimulated NHEK, in which IL-20 mRNA expression was
still upregulated 6.3 and 2.3 fold, respectively, compared
with vehicle, Po0.05 (data not shown).
IL-20 expression is rapidly induced in human keratinocytes
incubated with IL-1b
Among the selected stimuli, IL-1b was the most potent
inducer of IL-20 mRNA expression in NHEK. To investigate
the dynamics of IL-20 mRNA- and protein expression in
NHEK stimulated with IL-1b, time course studies were
conducted. Intra- and extracellular levels of total IL-20
protein were compared by multiplying the measured IL-20
concentration and total volume of whole-cell extract or
supernatant, respectively (Figure 1c).
IL-20 mRNA expression was upregulated within 30 min-
utes of stimulation with IL-1b, was maximal after 1 hour and
returned to base-line level after 4 hours (Figure 1b). The IL-
1b-mediated induction of IL-20 mRNA expression in NHEK
was dose dependent, reaching a maximal response at 5–10 ng
of IL-1b per ml (data not shown).
The IL-20 mRNA was translated within 3 hours and IL-20
protein was immediately released extracellularly into the
supernatant. After only 3 hours of incubation, the levels of
IL-20 protein were increased in the supernatant of the NHEK’s
stimulated with IL-1b (Figure 1c). IL-20 expression remained
increased in the supernatant of IL-1b-stimulated NHEK’s at 6,
12, and 24 hours of stimulation. Throughout all 48 hours, the
whole-cell extract level of IL-20 remained constant.
The p38 MAPK is a key regulator of IL-20 gene expression
To study the signal-transduction pathways regulating IL-20
expression, NHEK were incubated with inhibitors of the p38
MAPK (SB 202190), extracellular signal-regulated kinase (PD
98059) and protein kinase C (GF 109203X or Go 6983)
before IL-1b stimulation (Figure 2a).
Inhibition of protein kinase C did not change IL-20 mRNA
expression, whereas inhibition of extracellular signal-regu-
lated kinase downregulated the mean IL-20 mRNA expres-
sion by 34% in IL-1b-stimulated NHEK. Inhibition of the p38
MAPK, downregulated IL-20 mRNA expression to a level
even below vehicle-treated NHEK. In a separate set of
experiments the effect of p38 MAPK inhibition on both IL-20
mRNA and protein was determined. After treatment for
1 hour with either vehicle or IL-1b, IL-20 mRNA levels were
determined (Figure 2b) and after 6 hours of stimulation with
IL-1b, the IL-20 protein concentration in the supernatant was
determined. Incubation with SB 202190 before treatment
with vehicle resulted in a 96% downregulation of IL-20
mRNA expression compared with vehicle-treated NHEK. In
IL-1b-stimulated NHEK IL-20 mRNA expression was 10.4
compared with 0.23 in SB 202190 preincubated, IL-1b-
stimulated NHEK. The inhibition of IL-20 mRNA expression
was accompanied by a similar inhibition of IL-20 protein
expression (data not shown). As a positive control IkBa
mRNA expression was determined in the samples presented
in Figure 2b. IL-1b induced expression of IkBa mRNA
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irrespectively of SB 202190 preincubation reflecting that the
inhibitor allows the transcription of p38 MAPK-independent
genes (Figure 2c).
To further investigate the role of the p38 MAPK in the
expression of IL-20, NHEK were incubated with SB 202190
before stimulation with vehicle, UVB or IL-6 for 2 and
6 hours. Incubation with SB 202190 followed by stimulation
with UVB or IL-6 for 2 hours strongly downregulated IL-20
mRNA expression to a level even below that observed in
NHEK treated with vehicle (Figure 2d). Again SB 202190
without stimulation of the cells resulted in significantly lower
level of IL-20 mRNA expression than that observed in
unstimulated NHEK (Figure 2d). Incubation with SB 202190
before stimulation with UVB or IL-6 for 6 hours also resulted
in a significant downregulation of IL-20 mRNA expression
(data not shown).
IL-20 gene-expression is regulated through the NF-jB dimer
p50/p65
Phenylarsin oxide, an unspecific inhibitor of NF-kB, inhibited
IL-1b-induced IL-20 mRNA expression (Figure 2a). To further
assess the role of NF-kB in IL-20 mRNA expression a specific
IKK-b inhibitor (SC-514) was used.
Preincubation with SC-514 in IL-1b-stimulated NHEK
resulted in a 75% downregulation of IL-20 mRNA expression
(Figure 3a). Furthermore, SC-514 significantly downregulated
IL-20 mRNA expression in vehicle-treated keratinocytes. A
similar downregulation of IL-20 mRNA expression was found
when using BMS-345541 another IKK-b inhibitor (Burke
et al., 2003) (data not shown).
Through a search in the suspected promoter region of the
IL-20 gene two potential NF-kB-binding sites were identified,
which resembled the consensus sequence (Table 1). An
oligonucleotide fitting each of the two sites was designed and
an electrophoretic mobility shift assay (EMSA) carried out
(Figure 3b and c). We found that NF-kB binds to both
sequences shown in Table 1. To characterize the dimer
responsible for this binding we performed a supershift
analysis. Incubation of antibodies directed against p65 or
p50 both resulted in a complete supershift of the NF-kB band
(Figure 3b and c). This demonstrates that the p50/p65 dimer
binds upstream the start codon of the IL-20 gene. Finally, the
impact of SC-514 on NF-kB binding to the IL-20 oligonucleo-
tides was determined (Figure 3d). SC-514 decreased NF-kB
binding to both oligonucleotides in nuclear extracts from
NHEK stimulated with IL-1b.
The p38 MAPK does not regulate activation of NF-jB or binding
of the p50/p65-dimer to the IL-20 promoter
To examine if the p38 MAPK regulates IL-20 gene expression
through a direct activation of the NF-kB signaling pathway,
we preincubated NHEK with DMSO or SB 202190 before
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Figure 1. IL-1b rapidly induces IL-20 gene expression in NHEK. (a) IL-20 mRNA levels in normal human keratinocytes after 2 hours of incubation with various
stimuli. *Po0.05, compared with cells treated with vehicle, (n¼ 4 cultures). Bars indicate mean7SD. (b) Time course study of IL-20 mRNA expression (relative
to housekeeping gene 18 seconds rRNA) in NHEK during incubation with IL-1b (10 ng/ml). *Po0.05 and **Po0.001 compared with cells harvested upon
stimulation with IL-1b (n¼4). Bars indicate mean7SD. (c) Time course study of total IL-20 protein expression in NHEK during incubation with IL-1b (10 ng/ml)
(-’-: supernatant and -&-: whole-cell extract) or vehicle (-K-: supernatant and -J-: whole-cell extract). *Po0.05 compared with vehicle-treated keratinocytes
for the indicated times (n¼8). Points indicate mean7SEM.
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stimulation with IL-1b or vehicle. SB 202190 did not affect
the IL-1b-induced phosphorylation of IKK-b and IkBa, as
determined by Western Blotting (Figure 4a) and it did not
prevent NF-kB binding to the two IL-20 kB-binding oligo-
nucleotides (Figure 4b).
MSK1 is essential to IL-20 gene expression
At this point the p38 MAPK as well as NF-kB were shown to
be crucial for IL-20 expression. However, inhibition of the
p38 MAPK failed to prevent NF-kB activation. Therefore, we
decided to investigate the p38 MAPK-activated kinase:
mitogen- and stress-activated kinase 1 (MSK1) which is
known to increase the transcriptional activity of NF-kB. To
elucidate the roles of p38 MAPK and MSK1 in NF-kB
transactivation we analyzed the impact of SB 202190 or the
MSK1 inhibitor Ro 318220 on the phosphorylation of MSK1,
cAMP response element-binding protein (CREB)/activating
transcription factor 1(ATF1), p65 (ser276) and expression of
total IkBa. Total p65 expression was analyzed to verify equal
loading of the samples (Figure 5a and b). Stimulation with IL-
1b led to increased phosphorylation of MSK1. Ro 318220 did
not inhibit the IL-1b-induced phosphorylation of MSK1
whereas SB 202190 inhibited phosphorylation of MSK1 to a
level below that observed in vehicle-treated cells. To make
certain that the MSK1 kinase activity was effectively disrupted
by Ro 318220 and SB 202190, phosphorylation of the two
known MSK1 substrates, CREB and ATF1 were analyzed
(Wiggin et al., 2002). The presence of Ro 318220 or SB
202190 in NHEK, treated with either vehicle or stimulated
with IL-1b, resulted in a CREB/ATF1-phosphorylation level
even below that observed in keratinocytes treated only with
vehicle. To investigate how Ro 318220 and SB 202190
affected NF-kB, phosphorylation of p65 (ser276) was
analyzed. Similar to what was observed with CREB and
ATF1, the IL-1b-induced phosphorylation of p65 (ser276) was
inhibited to a level even below vehicle-treated cells. Finally,
we analyzed the expression of total IkBa to ascertain whether
or not Ro 318220 and SB 2021090 had any effect on the IKK-
NF-kB signaling pathway. Ro 318220 and SB 2021090 did
not affect degradation of IkBa. Furthermore, Ro 318220 did
not inhibit NF-kB binding to the IL-20 oligonucleotides in
nuclear extracts from NHEK stimulated with IL-1b for
30 minutes (data not shown).
We then studied how Ro 318220 affects IL-20 mRNA
expression (Figure 5c). Incubation with Ro 318220 before
treatment with vehicle resulted in a 93% downregulation of
IL-20 mRNA expression compared with vehicle-treated
NHEK. In IL-1b-stimulated NHEK IL-20 mRNA expression
was 10.4 compared with 0.07 in Ro 318220 preincubated, IL-
1b-stimulated NHEK.
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Figure 2. The p38 MAPK is a key regulator of IL-20 gene expression. (a) IL-20 mRNA expression in NHEK preincubated with specific inhibitors of: protein
kinase C (GF 109203X and Go 6983), extracellular signal-regulated kinase 1/2 (PD 98059), p38 MAPK (SB 202190), or an unspecific NF-kB inhibitor,
phenylarsin oxide and stimulated with IL-1b (10 ng/ml) for 1 hour. *Po0.01 compared with cells treated with vehicle. **Po0.01 and ***Po0.001 compared
with cells stimulated with IL-1b (n¼ 6). (b) IL-20 and (c) IkBa mRNA expression in NHEK with or without SB 202190 treated with vehicle or stimulated with
IL-1b (10 ng/ml) for 1 hour. (b) *Po0.001 and **Po0.05 compared with vehicle-treated cells. ***Po0.05 compared with cells stimulated with IL-1b.
(c) *Po0.05 compared with vehicle-treated cells (n¼5) (d) IL-20 mRNA expression in NHEK with or without SB 202190 treated with vehicle, UVB (250 J/m2)
and IL-6 (50 ng/ml) for 2 hours. *Po0.01 and **Po0.01 compared with cells treated with vehicle. ***Po0.001 compared with cells stimulated with UVB or
IL-6, (n¼ 5). (a–d) Bars indicate mean7SD.
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IL-1b activates the MAPK- and NF-jB- signaling pathways
through TAK1 and MEKK3
So far our results suggest that an activation of both the p38
MAPK and the NF-kB signaling pathway are required to
induce IL-20 expression. To determine where in the cascade
of IL-1b signaling the MAPK’s and NF-kB signaling pathway
were activated, we investigated the MAPK-kinase-kinases:
transforming growth factor-b-activated kinase (TAK1) and
MAPK kinase kinase 3 (MEKK3). Small-interfering (siRNA)
technology was used to knock down the expression of TAK1
and MEKK3. NHEK were transfected with control-, MEKK3-,
or TAK1 siRNA for 48 hours or as a control, left untransfected.
Gene silencing efficiency was verified with both Western
Blotting (Figure 6a) and quantitative real-time RT-PCR. In
TAK1 and MEKK3 siRNA-treated cells compared with control
and control siRNA-treated cells, mean TAK1 and MEKK3
mRNA expression was decreased by 72 and 67%, respec-
tively, Po0.001, n¼6 (data not shown). To determine the
role of TAK1 and MEKK3 in p38 MAPK (Figure 6b) and NF-kB
activation (Figure 6c) NHEK were transfected with TAK1- and
MEKK3 siRNA for 48 hours and stimulated with IL-1b for
5 minutes. We found a modest but significant and consistent
inhibition of IL-1b-induced p38 MAPK phosphorylation in the
TAK1 siRNA-transfected cells whereas transfection with
MEKK3 siRNA did not affect phosphorylation of the p38
MAPK (Figure 6b). Furthermore, transfection with TAK1
siRNA primarily inhibited phosphorylation of IKK-b and to
a lesser extent phosphorylation of IkBa (Figure 6c). Transfec-
tion with MEKK3 siRNA however, strongly inhibited phos-
phorylation of both IKK-b and IkBa (Figure 6c). TAK1 siRNA
transfection of NHEK stimulated with IL-1b for 20 minutes did
not lead to a significant inhibition of NF-kB binding to the
IL-20 kB-binding oligonucleotides whereas MEKK3 siRNA
transfection strongly inhibited this binding (Figure 6d).
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Figure 3. IL-20 gene expression is regulated by NF-jB. (a) IL-20 mRNA expression in NHEK preincubated with or without SC-514 and treated with vehicle
or IL-1b (10 ng/ml) for 1 hour. *Po0.05 and **Po0.05 compared with cells treated with vehicle. ***Po0.05 compared with cells stimulated with IL-1b,
(n¼4). Bars indicate mean7SD. (b and c) Characterization of NF-kB-binding activity to the region located upstream the IL-20 gene start codon (b)
oligonucleotide IL-20(B) and (c) oligonucleotide IL-20(B1). NHEK were treated with vehicle for 30 minutes (control) or stimulated with IL-1b (10 ng/ml) for
15 or 30 minutes. The nuclear fraction was isolated and IL-20 DNA-binding activity was determined by EMSA. Furthermore, a supershift analysis was
carried out with antibodies directed against p50 or p65. In the IL-1b-stimulated cells NF-kB-binding activity to the IL-20 promoter region was detected
whereas no binding activity to the control was present. When adding antibodies against p65 or p50 a supershift was observed. (NS¼ nonspecific bands).
(d) EMSA on nuclear extract from NHEK preincubated with or without SC-514 and treated with vehicle or IL-1b (10 ng/ml) for 30 minutes. (b–d) Representative
gels of at least three different experiments are shown.
Table 1. Potential NF-jB binding sites located
upstream from the start codon of the IL-20 gene
Consensus 50-GGGRNNYYCC-30
IL-20 Base pair 1586–1594 50-tggagtccc-30
IL-20 Base pair 2248–2256 50-gggaaactc-30
The consensus sequence of the classic NF-kB binding site is shown in the
top row (G, guanine, A, adenine, T, thymine, C, cytosine, R, purine, Y,
pyrimidine, and N, any nucleotide). Below are two regions from the IL-20
gene (along with their base pair numbers from the sequence found in
Entrez Nucleotide, locus AF402002) comparable with the consensus
sequence.
1330 Journal of Investigative Dermatology (2007), Volume 127
K Otkjaer et al.
Regulation of IL-20 Gene Expression
DISCUSSION
In this study, the proinflammatory stimuli, IL-1a, IL-1b, IL-6,
and UVB induced IL-20 expression in NHEK. IL-1b, a primary
proinflammatory cytokine and target in the treatment of
rheumatoid arthritis (Furst, 2004), proved to be the most
potent stimulus. IL-20 mRNA levels could be detected after
30 minutes of stimulation with IL-1b and reached a maximal
expression after only 1 hour. The newly synthesized IL-20
protein was immediately released from the cells and
increased levels of IL-20 could be detected in the supernatant
after only 3 hours of stimulation. In a previous study,
lipopolysaccharide-stimulated monocytes expressed in-
creased levels of IL-20 mRNA after 2 hours and the
expression returned to baseline levels within 6 hours. There-
fore, IL-20 was suggested as an early proinflammatory
cytokine (Wolk et al., 2002). Our findings demonstrate
proinflammatory stimuli to rapidly mobilize IL-20 and
indicate that IL-20 participates in the early phase of the
inflammatory cascade.
By using inhibitors of signal-transduction pathways, we
discovered IL-1b-induced IL-20 expression to be dependent
on p38 MAPK and NF-kB activity. The MAPKs are members
of discrete signaling cascades that are activated in response to
a variety of extracellular stimuli (Zarubin and Han, 2005).
These signaling pathways are known to be involved in cellular
events such as cell differentiation, proliferation, apoptosis and
inflammation. We identified the p38 MAPK as a key regulator
of IL-20 gene expression in NHEK. A p38 MAPK inhibitor
inhibited phosphorylation of MSK1, CREB/ATF1, p65 (ser276)
(Figure 5a) as well as IL-20 mRNA expression (Figure 2b and
d) to a level below that observed in vehicle-treated cells,
clearly suggesting a basal level of p38 MAPK activity to be
present in NHEK grown in vitro. IL-6 does not by itself
activate the p38 MAPK in NHEK (Haase et al., 2001).
However when the basal p38 MAPK activity is inhibited by
SB 202190 the IL-20 mRNA expression is decreased by more
than 90% in IL-6-treated NHEK (Figure 2d). Thus, not only
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Figure 5. The p38 MAPK regulates IL-20 gene expression through MSK1.
(a) Whole-cell extracts from NHEK treated with vehicle and NHEK
preincubated with DMSO, SB 202190 or Ro 318220 and stimulated with
IL-1b (10 ng/ml) for 15 minutes were prepared. Phospho-MSK1 and total p38
MAPK expression levels were analyzed by Western Blotting. (b) Whole-cell
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Representative gels of at least three different experiments are shown.
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p38 MAPK-activating stimuli such as IL-1 and UVB depend
on the activity of this kinase in IL-20 expression underscoring
the essential role for the p38 MAPK in IL-20 mRNA
expression in NHEK. This finding is in accordance with
a previous report of p38 MAPK mediated, lipopolysacchar-
ide-induced IL-20 mRNA expression in murine primary
cultured glial cells and a very recently published study
showing involvement of the p38 MAPK in UVB-induced IL-
20 mRNA expression in keratinocytes (Hosoi et al., 2004;
Hunt et al., 2006).
NF-kB proteins are dimeric transcription factors consid-
ered to be key mediators of inflammation, innate immunity,
and inhibition of apoptosis. We demonstrated a robust
downregulation of IL-20 gene expression after NF-kB inhibi-
tion with the nonspecific inhibitor phenylarsin oxide (Ves-
tergaard et al., 2005) and the specific IKK-b inhibitor SC-514
(Kishore et al., 2003; Karin et al., 2004). Furthermore, we
identified two NF-kB-binding sites in the suspected promoter
region of the IL-20 gene that specifically binds the p50/p65
heterodimer. These findings strongly indicate IL-20 as a NF-
kB-regulated gene.
Our results identify the p38 MAPK and the NF-kB as key
regulators of IL-20 expression which may indicate interaction
between these two signaling pathways. Inhibition of the p38
MAPK with SB 202190 did not affect phosphorylation of IKK-
b and IkBa or the binding of NF-kB to the two identified IL-20
kB-binding sites. Therefore, p38 MAPK must regulate IL-20
expression through an IKK-b-independent mechanism. The
p38 MAPK regulates expression of a number of genes through
activation of transcription factors and downstream kinases.
Specifically, the p38 MAPK signaling pathway has been
shown to regulate expression of proinflammatory genes such
as IL-6 and IL-8 through transactivation of the NF-kB
transcription factors (Schmeck et al., 2004; Zampetaki
et al., 2005). MSK1 is a downstream kinase of the p38 MAPK
and has been demonstrated to transactivate NF-kB driven
gene expression through phosphorylation of serine 276
(ser276) on the p65 subunit (Vermeulen et al., 2003). We
discovered inhibition of p38 MAPK activity to completely
abolish MSK1 phosphorylation. This finding is in accordance
with previous reports on MSK1 phosphorylation in IL-1b-
stimulated human keratinocytes (Funding et al., 2006;
Schiller et al., 2006). In this study, Ro 318220 was used to
inhibit MSK1 kinase activity. Beside MSK1, Ro 318220 has
been reported to inhibit the kinases: protein kinase C, p70
ribosomal protein S6 kinase, MAPK-1b and glycogen
synthase kinase-3b with a similar potency (Davies et al.,
2000). However, Ro 318220 inhibits the kinase activity of
MSK1 without disrupting the phosphorylation of MSK1
(Figure 5a) suggesting that p38 MAPK activity is unaffected.
This is in accordance with previous reports which also
demonstrated that the activity of several other kinases
activated by the p38 MAPK was largely unaffected by Ro
318220 (Deak et al., 1998; Davies et al., 2000; Schiller et al.,
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2006). In this work SB 202190 and Ro 318220 potently
inhibited IL-1b-induced phosphorylation of CREB, ATF1 and
p65 (ser276) (Figure 5a) as well as the expression of IL-20
mRNA (Figures 2a and 5b). Furthermore, it should be noted
that the p38 MAPK inhibitor SB 202190 does not abolish the
activity of protein kinase C, p70 ribosomal protein S6 kinase,
MAPK-1b, and glycogen synthase kinase-3b (Davies et al.,
2000). We, therefore, conclude that IL-1b activates MSK1
activity through a p38 MAPK-dependent mechanism and that
MSK1 is indeed essential to IL-20 gene expression most likely
as a result of its transactivating effect on NF-kB driven gene
expression. Thus, these findings do not exclude other kinases
downstream of the p38 MAPK to be involved in the
regulation of IL-20 mRNA and protein expression.
Both TAK1 and MEKK3 have been reported to be crucial
for IL-1 receptor and Toll-like receptor signaling through the
MAPK and NF-kB signaling pathway (Huang et al., 2004;
Sato et al., 2005). Because the role of TAK1 and MEKK3 in
IL-1 signaling in NHEK is unknown, we investigated their
impact on p38 MAPK and NF-kB signaling in NHEK. Our
findings confirmed TAK1 and MEKK3 to be involved in
IL-1-induced activation of IKK-b in NHEK whereas only TAK1
was shown to be involved in p38 MAPK activation. Although
knockdown of both MEKK3 and TAK1 resulted in an
inhibition of IL-1b-induced IKK-b activation a subsequent
inhibition of NF-kB binding was only observed when MEKK3
was knocked down. This can, at least in part, be explained by
residual TAK1 protein and redundancy of the signaling
pathways although different time kinetics could be another
explanation. This has not been further investigated in this
study.
IL-1bmRNA expression in lesional psoriatic skin is located
in the suprapapillar epidermis (Schmid et al., 1993), which
colocalizes with the reported location of IL-20 mRNA in
lesional psoriatic skin (Romer et al., 2003). In addition
increased levels of activated p38 MAPK and MSK1 have
previously been demonstrated in lesional psoriatic skin
(Johansen et al., 2005b; Funding et al., 2006). Increased
amounts of phosphorylated p65 in lesional psoriatic skin
(Lizzul et al., 2005) as well as increased NF-kB binding to
specific kB-binding sites in the promoter region of certain
proinflammatory cytokines and chemokines in lesional
psoriatic skin have also been reported (Johansen et al.,
2005a). It is intriguing to speculate that increased activity of
the p38 MAPK and NF-kB in lesional psoriatic skin may
explain the increased expression of IL-20 mRNA in psoriasis
(Romer et al., 2003; Otkjaer et al., 2005).
The study presented here provides new information about
signal transduction leading to IL-20 gene expression in
cultured NHEK. We demonstrate IL-20 expression to be
rapidly induced by selective proinflammatory stimuli. The
p38 MAPK and the IKK-NF-kB signaling pathways are crucial
for IL-1b-induced IL-20 expression and the simultaneous
activation of these two pathways are mediated through
activation of TAK1 and MEKK3. Furthermore, the p38 MAPK
was shown to exert its effects on IL-20 gene expression
through activation of the downstream kinase MSK1 indicating
transactivation of NF-kB driven IL-20 mRNA transcription as
a key mechanism of action. The identified signaling pathways
regulating IL-1b-induced IL-20 expression in NHEK are
summarized in Figure 7. These signaling pathways are
considered of major importance not only in inflammatory
disease but also cancer (Karin et al., 2004; Morel and
Berenbaum, 2004; Saklatvala, 2004). Therefore, the data
presented here warrant more research into the role of IL-20 in
inflammation and cell survival. Because IL-20 is assumed to
be a key cytokine in the pathogenesis of psoriasis and
possibly cancer, the p38 MAPK and NF-kB signaling path-
ways may be important new molecular targets for the
modulation of IL-20 expression in these diseases.
MATERIALS AND METHODS
Cell cultures
Normal adult human epidermal keratinocytes (NHEK) were obtained
by trypsinization of skin removed from patients undergoing plastic
surgery as previously described (Kragballe et al., 1985). First passage
keratinocytes were grown in serum-free keratinocyte growth media
with human recombinant epidermal growth factor, bovine pituitary
extract, and gentamicin (keratinocyte growth medium, KGM)
(Gibco/Invitrogen, Carlsbad, CA). Fresh media was added every
second day and cells were grown to approximately 60% confluency.
At this point, the growth factor supplemented media was changed to
non-growth factor supplemented media (keratinocyte basal medium,
KBM). After another 24 hours the cells were stimulated. Cytokines
and IFN-g were purchased from R&D Systems (Abingdon, UK). As
vehicle sterile phosphate-buffered saline with 0.15% BSA was used.
The UV source was a linear bank of UVB fluorescence tubes emitting
UVB light (Phillips TL12). The keratinocytes were grown in Petri
dishes or 6-well plates (TPP, Trasadingen, Switzerland) at 371C and
5% CO2.
This study was conducted in accordance with the Declaration of
Helsinki Principles. The medical ethical committee of Aarhus
approved the study. Informed consent was obtained from each
patient.
Inhibition of signal-transduction pathways
NHEK were incubated with inhibitors of specific signal-transduction
pathways. The inhibitors used are listed in Table 2. The inhibitors
were added 30 minutes before stimulation of the keratinocytes,
IL-20 mRNA
IL-20 transcription
IL-20 expression
IL-1 receptor
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IL-1
TAK1/MEKK3
p38 MAPKIKK-
IB
p50
p50
p65
p65
MSK-1
P
Figure 7. Signal-transduction pathways in the regulation of IL-20 gene
expression.
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except SC-514, which was added 1 hour before stimulation. All
inhibitors were purchased from Calbiochem, San Diego, CA except
phenylarsin oxide, which was from Sigma-Aldrich, St Louis, MO. All
inhibitors of signal-transduction pathways and the NF-kB pathway
were dissolved in DMSO to a final concentration of 0.1%, except
SC-514, which was dissolved to a final concentration of 0.2%.
RNA purification
The cell supernatant was discarded and while on ice the
keratinocytes were washed once in ice-cold sterile phosphate-
buffered saline (Gibco/Invitrogen). RNA was purified with SV Total
RNA Isolation System (Promega, Madison, WI). Briefly; 175 ml of SV
RNA lysis buffer was added and lysates prepared by manually
scraping the bottom of the wells. The lysates were transferred to
Eppendorf tubes and kept at 801C until RNA purification. The
lysates were thawed while on ice. SV RNA Dilution Buffer (350 ml)
was added and tubes inverted 10 times to mix. Samples were then
put on a heating block for 3 minutes at 701C and afterwards
centrifuged at 13,000 g, at room temperature for 10 minutes. Then
the supernatant was transferred to a new set of Eppendorf tubes.
A total of 200ml of 96% ethanol was added to the supernatant and
mixed by pipetting. The mixture was transferred to spin baskets
attached to a Vac-Man with Mini-Prep Vacuum Adapters (Promega).
Total RNA was purified according to the vacuum protocol, as
described by the manufacturer. Ultimately, RNA was dissolved in
RNase/DNase-free water and stored at 801C until further use.
Quantitative real-time RT-PCR
For reverse transcription, Taqman Reverse Transcription reagents
(Applied Biosystems, Foster City, CA) were used according to the
manufacturer’s instructions including the use of random hexamers as
primers. Reverse transcription thermal cycling was carried out using
a Peltier Thermal Cycler-200 (MJ Research, Inc. Waltham, MA).
Conditions were a 251C incubation step for 10 minutes, followed by
a 481C reverse transcription step for 30 minutes and finally a 951C
reverse transcriptase inactivation step for 5 minutes. Complementary
DNA was stored at 801C. Primers and probes were purchased from
Applied Biosystems. IL-20, IkBa, TAK1, MEKK3, and glyceralde-
hyde-3-phosphate dehydrogenase mRNA expression was deter-
mined with a Taqman 20 Assays-On-Demand (6-carboxy-
fluorescein-labelled MGB probes) gene expression assay mix (assay
ID: IL-20: Hs00218888_m1, IkBa: Hs00153283_m1, TAK1:
Hs00177373_m1, MEKK3: Hs00176747_m1, glyceraldehyde-
3-phosphate dehydrogenase: Hs99999905_m1). The housekeeping
gene used for normalization was 18 seconds rRNA (assay ID:
Hs99999901_s1). The expression of each gene was analyzed in
triplicates at a reaction volume of 25ml. PCR conditions were
2 minutes at 501C, 10 minutes at 951C followed by 50 cycles of
15 seconds at 951C, and 60 seconds at 601C. Real-time PCR machine
was a Rotorgene-3000 (Corbett Research, Sydney, Australia).
Relative gene expression levels were determined by using the
relative standard curve method as described previously (Otkjaer
et al., 2005).
ELISA
The supernatant was transferred to Eppendorf tubes and snap frozen
in liquid nitrogen. The cells were washed in ice-cold sterile
phosphate-buffered saline, snap frozen in liquid nitrogen and stored
at 801C until further use. Whole-cell extracts were prepared from
the keratinocytes. The six-wells were placed on ice and 120 ml cell
lysis buffer (20 mM Tris-Base pH 7.5, 150 nM NaCl, 1 nM EDTA, 1 mM
EGTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM
b-glycerolphosphate, 1 mM sodium orthovanadate, 1 mM phenyl-
methylsulfonyl fluoride and 1 Complete) were added to each well.
The bottom of the wells was scraped with a rubber policeman and
the samples were transferred to Eppendorf tubes. The samples were
then sonicated and centrifuged at 10,000 g for 10 minutes at 41C
after which the supernatant constitutes the cell lysate. Samples were
stored at 801C until ELISA analysis. IL-20 ELISA was performed in
96-well Maxisorp plates (Nunc, Roskilde, Denmark), using the IL-20
ELISA Development kit from Peprotech (Rocky Hill, NJ), according
to the manufacturers instructions. The final result was determined by
an ELISA reader (Victor, Wallac/PerkinElmer, Wellesley, MA) at 450/
620 nm. All measurements were performed in triplets. The range of
detection for the ELISA kit is 16–4,000 pg/ml, thus all measurements
below this range were increased to 16 pg/ml.
siRNA transfection
NHEK were grown in six wells until the cells were 40–50% confluent
at which point KGM was replaced by KBM without gentamicin
added. TAK1 (pool no: M-003790-05), MEKK3 (pool no: M-003301-
02), siRNA (Dharmacon, Lafayette, CO) were preincubated with
transfection reagent, Dharmafect-2 (Dharmacon) in KBM for
20 minutes. The formed siRNA/transfection regent complexes were
added to the wells in final concentration of 10 nM siRNA. As a
negative control, SiControl non-targeting pool siRNA (Dharmacon)
were used and the positive control was glyceraldehyde-3-phosphate
dehydrogenase siRNA (duplex no: D-001140-01) (Dharmacon).
Estimated by quantitative real-time RT-PCR, glyceraldehyde-3-
phosphate dehydrogenase knockdown was 90% in the glyceralde-
hyde-3-phosphate dehydrogenase siRNA-transfected cells (data not
shown), reflecting the transfection efficiency of our set-up. Five
hours after transfection the media was changed to KGM and the cells
were cultured for another 48 hours until stimulation.
Isolation of the nuclear fraction
Nuclear extracts were prepared as described previously (Rosette and
Karin, 1995). Briefly cells were scraped from the Petri dish by a
Table 2. Inhibitors of signal-transduction pathways
Inhibitor (conc.) Kinase
SB 202190 (10 mM) P38 MAPK
SC-514 (100 mM)
BMS 345541 (10 mM)
PAO (2.4 mM)
IKK-b/NF-kB
Ro 318220 (5 mM) MSK1
PD 98059 (50 mM) ERK 1/2
GF 109203X (210 nM)
Go 6983 (60 nM)
PKC
ERK, extracellular signal regulated kinase; IKK, inhibitory kB kinase;
MAPK, mitogen-activated protein kinase; MSK, mitogen- and
stress-activated kinase 1; PKC, protein kinase C; PAO, phenylarsin oxide.
The kinase inhibitors used in this study, the applied concentration (conc.)
and the target kinase.
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rubber policeman. The cells were diluted in a hypoton buffer (10 mM
N-2-hydroxyethylpiperazine-N0-2-ethanesulphonic acid, 10 mM KCl,
0.2 mM EDTA, 0.1 mM EGTA, 1 mM dithiothreitol, pH 7.9) and the
suspension passed through a 27 gauge needle six times and then
centrifuged at 10,000 g for 1 minute. Pellet was resuspended in a
hyperton buffer (20 mM N-2-hydroxyethylpiperazine-N0-2-ethanesul-
phonic acid, 0.4 mM NaCl, 1 mM EDTA and 1 mM dithiothreitol, pH
7.9) and rotated at 41C for 30 minutes before centrifuged at 10,000 g
for 5 minutes. The supernatant was considered the nuclear extract.
The protein concentration was determined as described previously
(Bradford, 1976) with BSA as standard.
EMSA
The promotor region of IL-20 (Entrez Nucleotide, accession no.
AF402002) was searched for potential NF-kB-binding sites, which
fitted the consensus sequence (Table 1). Oligonucleotides were
designed to match the two identified potential kB-binding sites and
purchased from DNA Technology (Aarhus, Denmark). The oligonu-
cleotides used for the gel shift analysis were: IL-20B,
50-GCGCTGTGGAGTCCCAGACACG-30, containing the suspected
kB site (base pair 1586–1594) in the region upstream from the start
codon of the IL-20 gene, IL-20B1, 50-GAGGAGGGGAAACTCAG
TAAGT-30, containing the other suspected kB site (base pair
2248–2256) in the region upstream from the start codon of the IL-
20 gene. Gel shift assays were performed as described previously
(Johansen et al., 2000). The oligonucleotides were labeled by T4
polynucleotide kinase. Labeled oligonucleotides were purified on a
Nick Spin column (G-50, Pharmacia, Uppsala, Sweden). In control
experiments a specific competitor (unlabelled IL-20B or IL-20B1
oligonucleotide) or a non-competitor (labelled AP1 consensus
oligonucleotide) were added 10 minutes before addition of labelled
IL-20B or IL-20B1 oligonucleotide. Finally, we created oligonucleo-
tides in which the kB-binding sequences of both the IL-20B and the
IL-20B1 oligonucleotides were mutated: IL-20B (mutated) 50-
GCGCTGTTTAGTGAGAGACACG-30 and IL-20B1 (mutated): 50-
GAGGAGTTTAAAGAGAGTAAGT-30. The mutations completely
removed the kB binding to the oligonucleotides (data not shown).
Western blot analysis
Cells were washed in ice cold phosphate-buffered saline and lysed
in a buffer containing 50mM Tris-HCl, pH 6.8, 10 mM dithiothreitol,
10 mM b-glycerophosphate, 10 mM sodium fluoride, 0.1 mM sodium
orthovanadate, 10% glycerol, 2.5% SDS added phenylmethylsulfo-
nyl fluoride and a cocktail of proteinase inhibitors (Roche,
Mannheim, Germany). The lysates were boiled for 3 minutes and
while on ice incubated with benzon nuclease for 30 minutes and
finally centrifuged for 13,600 g for 3 minutes. The supernatant was
transferred to a fresh Eppendorf tube and stored at 801C until
further use. Protein concentrations were determined with Bradford
analysis using albumin for the standard curve and equal amounts of
whole-cell extracts were separated with SDS-PAGE and blotted onto
nitrocellulose membranes. Membranes were incubated with primary
antibodies and detected by horseradish peroxidase-conjugated
secondary antibodies in a standard enhanced chemiluminescence
reaction (GE Healthcare, Wessling, Germany). Primary anti-phos-
pho-IKK, -phospho-IkBa, -phospho-p38 MAPK, -phospho-MSK1
(ser376), -phospho-CREB, -IKK, -p38 MAPK, -p65 and TAK1
antibodies were from Cell Signaling Technology, Beverly, MA;
anti-IkBa antibody was from Santa Cruz Biotechnology, Santa Cruz,
CA; anti-MEKK3 antibody was from BD Pharmingen, San Jose, CA.
Secondary anti-rabbit antibody was from Cell Signaling Technology
and anti-mouse antibody was from DAKO, Glostrup, Denmark.
A prestained marker (Invitrogen, Carlsbad, CA) and a biotinylated
marker (Cell Signaling Technology) were used for estimation of
protein weight.
Flow cytometry
Three primary cultures from different individuals were harvested and
stained using antibodies against CD14 and CD1a in order to exclude
immune competent cells. Cells were harvested by trypsinization and
trypsin action was stopped using culture medium containing 10%
fetal calf serum. Cells were then resuspended in culture medium
containing 10% fetal calf serum and antibodies against CD14 and
CD1a (BD Pharmingen) conjugated to phycoerythrin and FITC
respectively and incubated for 30 minutes on ice. The cells were
then washed and resuspended in medium containing propidium
iodide at 5 mg/ml. Live cells negative for CD14, CD1a, and
propidium iodide were sorted using a standard FACSAria (Becton
Dickinson, San Jose, CA). An aliquot of the sorted cells were fixed in
paraformaldehyde, permeabilized in Triton X-100, and stained for
keratin-14 content using a directly conjugated antibody (mAb LL002,
a kind gift from Dr Irene Leigh, conjugated to Alexa 488) or isotyped
control.
Statistical analysis
The significance of differences in IL-20 mRNA levels and IL-20
protein levels were determined by Student’s t-test (two tailed). To test
for normal distribution a probability test was made.
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